Infinimmune

Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.

Website: infinimmune.com.

X: @infinimmune · 139 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: biotech.

Stage: Series A.

Based in: Alameda, United States.

On Recent Funding since: Sep 28, 2026.

Signals

X account@infinimmune · created Aug 15, 2022 (4 years old) · 139 followers

Website registeredSep 23, 2021 (5 years old)

WM
Wyatt McDonnell CEO & Co-Founder

LinkedIn · source: infinimmune.com
DJ
David Jaffe Infinimmune Fellow & Co-Founder

source: infinimmune.com
KP
Katie Pfeiffer Chief Technology Officer & Co-Founder

source: infinimmune.com
LH
Lance Hepler Chief Information Officer & Co-Founder

source: infinimmune.com
MG
Mike Gibbons Chief Scientific Officer & Co-Founder

source: infinimmune.com
AS
Anthony Slavin Senior Vice President of Portfolio Strategy
SP
Srikanth Pendyala Chief Medical Officer
TS
Tim Sullivan CBO

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/infinimmune (get a free API key).